On September 11, SELLAS Life Sciences Group Inc. fell 9.35% in regular trading, trading at $12.28 USD/share, with Turnover of $88.60 million.
Within the Biotechnology sector where SELLAS Life Sciences Group Inc. belongs, individual stocks showed mixed performance. Among individual stocks, Moderna, Inc. up 8.73%, AbbVie up 1.04%, Hyperliquid Strategies Inc up 5.99%, Amgen down 0.88%, Gilead Sciences down 0.53%.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)